CHAPEL HILL, N.C., Feb 09, 2006 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ: POZN) announced today that John R.
Plachetka, Pharm.D., the company's chairman, president and chief
executive officer, will present as part of a panel entitled, "Cure the
Pain," at the BIO CEO & Investor Conference on Tuesday, February 14,
2006 at 4:00 p.m., ET, in the Basildon Room at The Waldorf-Astoria,
New York, NY.
The panel presentation will be available via webcast beginning
February 15, 2006 and can be viewed on the BIO website at:
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of acute and chronic
pain, migraine, and other pain-related conditions. POZEN has a
development and commercialization alliance with GlaxoSmithKline. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
SOURCE: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
Fran Barsky, 919-913-1044
Director, Investor Relations